Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism

NCT02029456 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Embolism

Interventions

DRUG: 25 mg Actilyse ( Boehringer Ingelheim, Germany) infusion in 6 hours

Sponsor

Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital